WellPoint Inc
featured
The vote to split roles for JPMorgan Chase Chairman and CEO Jamie Dimon on Tuesday could be driven by big index funds, as well as by Institutional Shareholder Services
» Read More
More
-
*Barclays raises price target to $81 from $72. Reuters Station users, click. 1568. Reuters Station users, click. 4899.
-
The Dow dipped while the S&P 500 edged up on Wednesday as a sharp drop in durable goods orders last month added to worries about slower U.S. economic activity and Apple's results disappointed investors. **BOEING CO, $91.15, up 3.3 pct. **APPLE INC, $401.20, down 1 pct.
-
*1st- quarter EPS of $2.94 beats Wall Street view of $2.39. April 24- WellPoint Inc's quarterly profit came in far above Wall Street expectations, helped by expansion of individual health insurance plans and Medicaid membership, as well as lower medical costs from plans sold to small businesses.
-
April 24- WellPoint Inc's first-quarter profit rose after the acquisition of Amerigroup boosted consumer business and medical costs were less than expected in the group that sells plans to small businesses, the U.S. health insurer said on Wednesday.
-
April 24- WellPoint Inc, the second-largest U.S. health insurer, reported a higher first-quarter profit on Wednesday, helped by the acquisition of Amerigroup in December, and it raised its 2013 earnings outlook. WellPoint reported a profit of $885.2 million, or $2.89 per share, up from $856.5 million, or $2.53 per share, a year earlier.
-
April 24- WellPoint Inc, the second-largest U.S. health insurer, said on Wednesday that its first-quarter profit rose, helped by the acquisition of Amerigroup in December, and it raised its 2013 earnings outlook to reflect better performance. WellPoint reported a profit of $885.2 million, or $2.89 per share, up from $856.5 million, or $2.53 per share, a year earlier.
-
Apple briefly got some of its shine back, after it delivered a package of capital programs that shareholders have been clamoring for.
-
It's make-or-break time for the first-quarter earnings season, and it comes just as the stock market is showing signs of strain.
-
Stocks extended their losses for a second day Thursday, dragged by health care and techs, after a batch of economic data that missed projections and mixed earnings reports.
-
With earnings for health insurers kicking off Thursday, the market's focus will be on the impact of health reform in 2014.
-
Check out which companies are making headlines after the bell Thursday:
-
April 2- Humana Inc said on Tuesday that the government's increase in its payment rate for Medicare Advantage in 2014 is an improvement over a proposed reduction but said that "meaningful challenges" in certain geographical areas are ahead.
-
With only six months before the start of enrollment for Obamacare, state and federal health officials are racing to get insurance regulations and systems up and running in time.
-
Walk-in clinics are popping up in shopping malls and main streets across the United States, and private equity is helping fund the expansion.
-
NEW YORK, March 21- Walk-in clinics are popping up in shopping malls and main streets across the United States and private equity is helping fund the expansion. The number of such clinics in the United States climbed almost 20 percent to 9,400 in the last four years, according to the Urgent Care Association of America.
-
Carl Icahn bought 14 million shares of Herbalife, making a major bet against Pershing Square's Bill Ackman, who is short the stock. The two had an epic showdown on CNBC last month .
-
*Humana profit of $1.19 a share beats Wall St view of $1.06. Feb 4- Health insurer Humana Inc reported a drop in fourth-quarter profits on Monday and said it was experiencing the worst flu season in a decade that would cost $75 million for added healthcare services such as hospitalizations.
-
Shawn Guertin, who has been with Aetna since 2011 and was previously CFO of Coventry Health Care Inc, which Aetna is buying, will replace Zubretsky on Feb. 25. The Hartford, Connecticut company announced plans in August for the $5.6 billion acquisition of Coventry, part of a strategy to expand in government-sponsored healthcare programs like Medicare.